Case File №
#VI-2026-0994
Peptide Crafters
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
44 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A Great | 10 | 8.3 | 6.4 | 9.0 | 17 Dec 2024 |
| Retatrutide | A Great | 6 | 7.6 | 6.6 | 9.5 | 17 Dec 2024 |
| Ipamorelin | B Good | 4 | 6.5 | 6.1 | 7.2 | 27 Feb 2025 |
| Melanotan II | C Okay | 4 | 5.1 | 4.6 | 5.5 | 27 Feb 2025 |
| Tirzepatide | C Okay | 5 | 5.8 | 4.2 | 7.8 | 17 Dec 2024 |
| CJC-1295 | D Poor | 4 | 5.0 | 4.3 | 5.9 | 28 Feb 2025 |
| BPC-157 | D Poor | 6 | 6.6 | 4.0 | 8.9 | 17 Dec 2024 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 2 | 6.2 | 5.6 | 6.7 | 24 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 2 | 6.9 | 5.8 | 8.1 | 24 May 2026 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 2 | 7.6 | 6.9 | 8.3 | 24 May 2026 |
| AHK-CU | X N/A | 3 | 6.0 | 4.8 | 6.9 | 23 May 2026 |
| AICAR | X N/A | 1 | 4.5 | 4.5 | 4.5 | 3 Jun 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 2 | 6.7 | 6.4 | 6.9 | 23 May 2026 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 2 | 6.7 | 5.0 | 8.4 | 24 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 2 | 6.7 | 6.3 | 7.0 | 20 May 2026 |
| Cerebrolysin | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| CJC-1295 With DAC | X N/A | 3 | 6.8 | 5.3 | 8.3 | 26 Jan 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 8.3 | 8.3 | 8.3 | 2 Jul 2025 |
| Clenbuterol | X N/A | 3 | 5.9 | 5.4 | 6.4 | 17 May 2026 |
| Crystagen | X N/A | 2 | 6.6 | 6.2 | 7.0 | 26 Jan 2026 |
| DHB (1-Test Cyp) Oral | X N/A | 2 | 6.7 | 6.4 | 7.0 | 21 May 2026 |
| Dianabol | X N/A | 2 | 6.9 | 6.9 | 6.9 | 17 May 2026 |
| Enclomiphene | X N/A | 3 | 6.6 | 5.3 | 8.0 | 21 May 2026 |
| Finasteride | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 8.9 | 8.9 | 8.9 | 13 Jun 2025 |
| GW-501516 (Cardarine) Raw | X N/A | 1 | 5.6 | 5.6 | 5.6 | 6 May 2025 |
| HMG | X N/A | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 |
| Letrozole | X N/A | 3 | 6.2 | 3.9 | 7.6 | 20 May 2026 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| Methylamine (base) CAS 74-89-5 | X N/A | 2 | 5.8 | 4.7 | 6.8 | 24 May 2026 |
| Methylamine hydrochloride CAS 593-51-1 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 20 Jun 2025 |
| MGF | X N/A | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 |
| NAD+ | X N/A | 2 | 8.6 | 8.1 | 9.2 | 23 May 2026 |
| Ostarine (MK-2866) | X N/A | 2 | 9.1 | 8.4 | 9.7 | 23 May 2026 |
| Oxytocin Acetate | X N/A | 2 | 8.0 | 7.0 | 9.0 | 17 May 2026 |
| P21 | X N/A | 2 | 6.6 | 5.0 | 8.2 | 20 May 2026 |
| PE 22-28 | X N/A | 2 | 7.2 | 5.7 | 8.6 | 23 May 2026 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 |
| Propionyl chloride CAS 79-03-8 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Prostamax | X N/A | 2 | 4.8 | 4.4 | 5.2 | 21 May 2026 |
| Semax | X N/A | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| SS-31 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 1 | 6.1 | 6.1 | 6.1 | 6 May 2025 |
| Vesugen | X N/A | 3 | 6.7 | 6.0 | 7.4 | 25 May 2026 |
Exhibit II
Evidence Log
72 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Oxytocin Acetate | 9.2 A | 2mg | 2.1mg | +4.9% | 99.02% | kg0vyj | Lab B | Community |
| 25 May 2026 | Vesugen | 7.2 A | 20mg | 20.8mg | +3.8% | 96.60% | w8s6fu | Lab A | Public |
| 24 May 2026 | 4-Piperidone CAS 41661-47-6 | 6.5 A | 1g | 1.2g | +19.3% | 98.98% | zm0nz1 | Lab G | Public |
| 24 May 2026 | AHK-CU | 6.3 A | 30mg | 33.6mg | +12.0% | 98.30% | uva3rv | Lab D | Public |
| 24 May 2026 | AHK-CU | 5.4 B | 10mg | 9.3mg | -7.1% | 98.74% | fkx8fr | Lab A | Public |
| 24 May 2026 | MGF | 10.0 A | 50mg | 54.3mg | +8.6% | 97.59% | 1qpf8i | Lab D | Public |
| 24 May 2026 | Prostamax | 4.3 C | 20mg | 17.3mg | -13.6% | 95.65% | it4m00 | Lab A | Public |
| 24 May 2026 | Prostamax | 4.3 C | 50mg | 51.0mg | +2.0% | 97.50% | btdbj9 | Lab E | Community |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.9 A | 20mg | 19.4mg | -3.2% | 96.21% | bn5yv1 | Lab F | Community |
| 24 May 2026 | GW-501516 (Cardarine) Raw | 6.1 A | 100g | 85.9g | -14.1% | 96.77% | x77tv8 | Lab E | Public |
| 24 May 2026 | Propionyl chloride CAS 79-03-8 | 5.5 B | 1g | 1.2g | +22.0% | 97.76% | oi0ha6 | Lab C | Public |
| 24 May 2026 | Semax | 10.0 A | 2mg | 1.8mg | -7.8% | 97.65% | s4yu1m | Lab A | Public |
| 24 May 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 7.1 A | 10g | 9.0g | -10.0% | 95.63% | uyn7dp | Lab D | Community |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.2 A | 500g | 515.0g | +3.0% | 96.92% | h8kid0 | Lab B | Public |
| 24 May 2026 | Crystagen | 6.5 A | 2mg | 1.9mg | -2.8% | 97.08% | stiimk | Lab E | Community |
| 24 May 2026 | Ostarine (MK-2866) | 8.7 A | 20mg | 21.9mg | +9.6% | 95.29% | 6uxa8t | Lab F | Community |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.5 A | 50mg | 55.8mg | +11.6% | 99.21% | t5b778 | Lab A | Public |
| 23 May 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 4.9 C | 300mg/ml | 363.0mg/ml | +21.0% | 95.80% | r459ab | Lab F | Public |
| 23 May 2026 | P21 | 6.2 A | 50mg | 46.8mg | -6.4% | 96.14% | z47w11 | Lab D | Public |
| 23 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.1 A | 2mg | 2.0mg | +1.8% | 96.88% | q8mlbp | Lab A | Community |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 9.8 A | 1g | 1.1g | +13.3% | 97.58% | qi61c9 | Lab A | Public |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.1 A | 10mg | 8.7mg | -13.4% | 99.82% | 8w61lf | Lab A | Public |
| 21 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.4 A | 50mg | 61.8mg | +23.5% | 97.80% | zqdao9 | Lab F | Community |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 4.9 C | 25mg | 30.7mg | +22.9% | 95.95% | s84yoz | Lab D | Public |
| 21 May 2026 | P21 | 6.4 A | 30mg | 27.0mg | -10.0% | 98.91% | 005fbq | Lab C | Public |
| 21 May 2026 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 7.3 A | 1g | 1.1g | +11.3% | 98.05% | d05yzd | Lab F | Community |
| 21 May 2026 | PE 22-28 | 5.4 B | 30mg | 30.9mg | +3.0% | 98.36% | lm3qw2 | Lab F | Community |
| 20 May 2026 | Crystagen | 6.0 A | 2mg | 2.1mg | +5.7% | 99.26% | 8xssy4 | Lab E | Community |
| 19 May 2026 | Letrozole | 7.0 A | 20mg | 20.0mg | +0.2% | 99.90% | lddtlw | Lab C | Public |
| 19 May 2026 | Methylamine (base) CAS 74-89-5 | 7.5 A | 5g | 4.9g | -2.4% | 98.73% | 8gmfll | Lab A | Public |
| 17 May 2026 | AICAR | 4.2 C | 10mg | 11.7mg | +17.1% | 98.65% | 5ihk3f | Lab A | Public |
| 17 May 2026 | Enclomiphene | 7.2 A | 50mg | 55.4mg | +10.8% | 95.28% | i958iz | Lab E | Public |
| 29 Jan 2026 | Clenbuterol | 5.4 B | 20mg | 19.9mg | -0.7% | 95.55% | 22sjdo | Lab G | Public |
| 26 Jan 2026 | Cerebrolysin | 5.9 B | 5mg | 6.2mg | +24.9% | 96.61% | ufyngj | Lab D | Public |
| 26 Jan 2026 | DHB (1-Test Cyp) Oral | 8.2 A | 50mg | 56.1mg | +12.2% | 95.68% | wfs04e | Lab B | Community |
| 26 Jan 2026 | Enclomiphene | 5.6 B | 20mg | 23.7mg | +18.7% | 97.63% | v2xv2n | Lab G | Public |
| 19 Jan 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.4 A | 1g | 1.2g | +24.4% | 97.17% | 8h9987 | Lab G | Public |
| 19 Jan 2026 | CJC-1295 With DAC | 4.7 C | 5mg | 5.3mg | +5.6% | 99.61% | ck9z5a | Lab D | Public |
| 19 Jan 2026 | Methylamine (base) CAS 74-89-5 | 6.2 A | 1g | 0.9g | -9.0% | 98.95% | w1gmx3 | Lab E | Public |
| 9 Jan 2026 | Dianabol | 7.9 A | 100mg | 87.4mg | -12.6% | 96.36% | 5dilcm | Lab A | Public |
| 7 Jan 2026 | Enclomiphene | 9.1 A | 50mg | 58.6mg | +17.3% | 98.68% | 0wqyzd | Lab A | Community |
| 7 Jan 2026 | NAD+ | 9.1 A | 5mg | 6.1mg | +22.2% | 98.14% | rnlp9d | Lab A | Public |
| 6 Jan 2026 | CJC-1295 With DAC | 6.4 A | 20mg | 22.4mg | +11.8% | 95.53% | yozsj4 | Lab E | Public |
| 6 Jan 2026 | Clenbuterol | 7.3 A | 10mg | 10.4mg | +4.2% | 96.98% | xhfzdp | Lab D | Public |
| 29 Dec 2025 | BPC-157 | X | 7.8 | 10mg | (no batch claim) | 11.4mg | +14.0% | 11-18-25 | (no data) |
| 16 Dec 2025 | Retatrutide | X | 9.5 | 15mg | (no batch claim) | 15.6mg | +4.0% | PC-G2-RT15 | White & Yellow Label / Silver Crimp / Red Cap |
| 12 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.6 A | 15mg | 13.3mg | -11.0% | 97.16% | zm5cv1 | Lab D | Public |
| 12 Dec 2025 | Ostarine (MK-2866) | 10.0 A | 25mg | 24.8mg | -0.9% | 99.08% | 9ufttr | Lab D | Community |
| 5 Dec 2025 | Finasteride | 6.5 A | 25mg | 28.3mg | +13.3% | 95.58% | 94zuna | Lab D | Public |
| 5 Dec 2025 | HMG | 4.0 C | 30mg | 26.1mg | -13.1% | 99.08% | 4pza1x | Lab G | Public |
| 23 Nov 2025 | AHK-CU | 5.0 B | 2mg | 2.1mg | +3.8% | 98.54% | 85sqk9 | Lab C | Public |
| 23 Nov 2025 | Dianabol | 5.7 B | 50mg | 56.5mg | +12.9% | 98.84% | cz30gg | Lab F | Community |
| 23 Nov 2025 | Letrozole | 5.8 B | 50mg | 53.4mg | +6.7% | 98.17% | ajfxqp | Lab F | Public |
| 17 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.4 A | 2mg | 2.4mg | +20.6% | 98.98% | e61f8l | Lab E | Public |
| 14 Nov 2025 | 4-Piperidone CAS 41661-47-6 | 8.9 A | 10g | 11.0g | +9.9% | 98.81% | kekr72 | Lab F | Public |
| 14 Nov 2025 | Clenbuterol | 5.8 B | 20mg | 20.1mg | +0.7% | 99.40% | ugauq0 | Lab C | Community |
| 14 Nov 2025 | SS-31 | 5.2 B | 50mg | 45.1mg | -9.8% | 97.58% | h4ia6c | Lab C | Public |
| 5 Nov 2025 | Letrozole | 7.8 A | 20mg | 21.7mg | +8.5% | 96.78% | 79449k | Lab B | Public |
| 5 Nov 2025 | Oxytocin Acetate | 7.5 A | 30mg | 28.2mg | -5.8% | 96.17% | bziqv4 | Lab A | Community |
| 5 Nov 2025 | PE 22-28 | 8.2 A | 50mg | 48.2mg | -3.6% | 96.50% | b48qmz | Lab F | Community |
| 5 Nov 2025 | Vesugen | 6.5 A | 5mg | 5.1mg | +2.5% | 97.07% | okvi1c | Lab E | Community |
| 4 Nov 2025 | Methylamine hydrochloride CAS 593-51-1 | 10.0 A | 100g | 102.0g | +2.0% | 97.74% | 7mzlbx | Lab C | Public |
| 4 Nov 2025 | Vesugen | 6.8 A | 15mg | 15.3mg | +1.8% | 95.97% | 3y0gnx | Lab B | Community |
| 17 Oct 2025 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 7.4 A | 500g | 472.4g | -5.5% | 97.67% | hpbpcj | Lab D | Public |
| 9 Oct 2025 | CJC-1295 With DAC | 5.4 B | 50mg | 58.9mg | +17.9% | 96.39% | umuem6 | Lab D | Public |
| 9 Oct 2025 | NAD+ | 7.7 A | 10mg | 12.0mg | +20.1% | 98.90% | ep4qmc | Lab F | Community |
| 3 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 6.9 A | 50mg | 52.2mg | +4.5% | 97.38% | o7ljqx | Lab D | Public |
| 20 Mar 2025 | BPC-157 | X | 5.0 | 10mg | 11.7mgwebsite | 13.75mg | +17.9% | PC-Z1-BP10 | Yellow, Black, White Label / Purple Crimp / Clear Cap |
| 20 Mar 2025 | Melanotan II | X | 4.7 | 10mg | 13.0mgwebsite | 8.18mg | -37.2% | PC-Z-MT210 | Yellow, Black, White Label / Silver Crimp / Clear Blue Cap |
| 20 Mar 2025 | CJC-1295 | DAC X | 5.3 | 5mg | 5.2mgwebsite | 4.84mg | -6.9% | PC-Z-CJCDAC | Yellow, Black, White Label / Silver Crimp / Orange Cap |
| 20 Mar 2025 | Semaglutide | X | 8.9 | 15mg | 16.2mgwebsite | 16.76mg | +3.4% | PC-J-S15 | Yellow, Black, White Label / Silver Crimp / Black Cap |
| 20 Mar 2025 | Ipamorelin | X | 6.6 | 10mg | 13.0mgwebsite | 14.8mg | +14.0% | PC-Z1-IP10 | Yellow, Black, White Label / Silver Crimp / Clear Cap |
— END OF EVIDENCE LOG —